At the Fifth Global Symposium on Health Systems Research in Liverpool in October, RHINO hosted interactive panel which discussed innovative approaches used in low-to-middle income countries to strengthen routine health information systems with the greater goal of achieving universal health coverage (UHC). Panelists discussed: creating community accountability; using human-centered design to build a culture of data use; electronic tools for data management and progress tracking toward UHC; and the Data Use Partnerships in Ethiopia, Tanzania, and Malwai. Presented by Tariq Azim.
Karen Minyard, GHPC Director, presented "Social Determinants of Health Equity and Levels of Potential Impact in the System: Opportunities for Leverage" at the Georgia Grantmakers Alliance in Macon, GA on August 25, 2011.
EOA2016: Integrating Care for Whole Person HealthPIHCSnohomish
During the 2nd session of Edge of Amazing 2016, this session highlighted the work being accomplished under fully integrated managed care in WW Wa., progress in other regions and at a state level to integrate behavioral health, and the role of community in ensuring whole-person care. While highlighting work from the North Sound ACH.
Vanessa Gaston, Clark County Human Services
Isabel Jones - Washington State Health Care Authority
Joe Valentine - North Sound Behavioral Health Organization
Karen Minyard, GHPC Director, presented "Social Determinants of Health Equity and Levels of Potential Impact in the System: Opportunities for Leverage" at the Georgia Grantmakers Alliance in Macon, GA on August 25, 2011.
EOA2016: Integrating Care for Whole Person HealthPIHCSnohomish
During the 2nd session of Edge of Amazing 2016, this session highlighted the work being accomplished under fully integrated managed care in WW Wa., progress in other regions and at a state level to integrate behavioral health, and the role of community in ensuring whole-person care. While highlighting work from the North Sound ACH.
Vanessa Gaston, Clark County Human Services
Isabel Jones - Washington State Health Care Authority
Joe Valentine - North Sound Behavioral Health Organization
Raymond J. Baxter, PhD, senior vice president, Community Benefit, Research and Health Policy at Kaiser Permanente presents a keynote address at the Forum for Healthy Behavior Change in Washington, D.C. on May 16, 2013.
Dr. Baxter addresses the need to create systematic changes that eventually become habits, to encourage healthy behavior change and combat the obesity epidemic.
mathernal health on 4 delays during facility services by Girma Huka DukaleGirmaaHuqqaa
This power point is used for students,teacher,and for any organization those like to use as references of their study.The portion of this part should not transmitted in any means to without permission of this group.
Bryan Tomlinson, MPH, Director, Division of Health Care Services, Virginia Department of Medical Assistance Services discusses Virginia's Medicaid medical home pilot project.
As countries continue to invest and make strides toward achieving the SDGs and universal health coverage, strong routine health information systems (RHIS) are fundamental to the effort. Well-functioning RHIS provide a wealth of data on a country’s health system, including service delivery, availability of a trained workforce, and reach of interventions, that can be harnessed to identify gaps and support evidence-based decision making. Yet, while many low-to-middle income (LMIC) countries have established a national RHIS structure, there are existing challenges related to the availability, analysis, and use of the data that have yet to be addressed.
Raymond J. Baxter, PhD, senior vice president, Community Benefit, Research and Health Policy at Kaiser Permanente presents a keynote address at the Forum for Healthy Behavior Change in Washington, D.C. on May 16, 2013.
Dr. Baxter addresses the need to create systematic changes that eventually become habits, to encourage healthy behavior change and combat the obesity epidemic.
mathernal health on 4 delays during facility services by Girma Huka DukaleGirmaaHuqqaa
This power point is used for students,teacher,and for any organization those like to use as references of their study.The portion of this part should not transmitted in any means to without permission of this group.
Bryan Tomlinson, MPH, Director, Division of Health Care Services, Virginia Department of Medical Assistance Services discusses Virginia's Medicaid medical home pilot project.
As countries continue to invest and make strides toward achieving the SDGs and universal health coverage, strong routine health information systems (RHIS) are fundamental to the effort. Well-functioning RHIS provide a wealth of data on a country’s health system, including service delivery, availability of a trained workforce, and reach of interventions, that can be harnessed to identify gaps and support evidence-based decision making. Yet, while many low-to-middle income (LMIC) countries have established a national RHIS structure, there are existing challenges related to the availability, analysis, and use of the data that have yet to be addressed.
Partnering with Patients, Families and Communities for Health: A Global Imper...EngagingPatients
Engagement is an essential tool to improving global health. This report introduces a new framework for engagement to help countries assess current programs and think strategically about future engagement opportunities. It spotlights barriers to engagement and offers concrete examples of effective engagement from around the globe.
Foundational Learning in Social Determinants of Health for Health Professionals by Dr. Haydee Encarnacion Garcia. Presented at the Emerging Trends in Nursing Conference at Indiana Wesleyan University on June 1, 2017.
Acting on Social Determinants and Health Equity: Opportunities and Promising ...Wellesley Institute
This presentation looks at the opportunities and practices that establish an effective public health system.
Bob Gardner, Director of Policy
www.wellesleyinstitute.com
Follow us on twitter @wellesleyWI
Strengthening Community Capacity for Effective Advocacy: A Strategy Developme...Humentum
Robert Musoke, PATH Uganda; Bernard Byagageire, PATH Uganda; Jennifer Gaberu, PATH Uganda. Presentation made during Humentum's Capacity for Humanity conference, February 2018.
Health Equity for Immigrants and Refugees: Driving Policy ActionWellesley Institute
This presentation discusses health equity for immigrants and refugees.
Bob Gardner, Director of Policy
www.wellesleyinstitute.com
Follow us on twitter @wellesleyWI
Australia's health system needs to better connect the dots in a number of areas. Our work looks at connections between Australian chronic disease targets and indicators, WHO targets and indicators, and national progress.
Budget RESEARCHBudget Template - page 1 of 2GRANT(For Internal Use.docxAASTHA76
Budget RESEARCHBudget Template - page 1 of 2GRANT(For Internal Use Only - see specific sponsoringTitle:Union County of Georgia cancer prevention programagency for the proper forms)Date:12-May-17RFA no.PI:Project Period:2017/2018Budget Period:2017-2018Year 1Field researchResearch assitants( Salaries & benefits)250,000Transport120,000Research tools( questionaires and interviews)50,000420,000Screening actvitiesLocal hospital staff service fees80,000Electricity consumed by equipment20,000Maintenace expenses40,000140,000MarketingNutrionists service fees150,000Local gym service15,000Formation of chamber fo commerce180,000Education workshops ( schools and community centers)50,000395,000
pasterme:
rate as of 7/1/05
subject to change
confirm with the SPH
Business Office
pasterme:
part-time student rate as of 7/1/04 subject to change confirm with the SPH Business Office
pasterme:
rate subject to change Please review all budgets with the SPH
Business Office.
Running head: COMMUNITY COALITION 1
COMMUNITY COALITION 3
Community Coalition
Kimberly Crawford
Kaplan University
January 8, 2018
Community Coalition
1. Choose 5 partnerships to engage and explain why you would invite each of these people//organizations to be a part of the coalition.
The creation of community health promotion and education programs takes into consideration several agencies or parties who help in the achievement of the desired health goals. Each of the partners will address its roles using different approaches depending on their area of expertise. This is an important factor to consider as different institutions address health promotion using different approaches and perspectives. The overall outcome from the contribution of every partner should be able to restore and promote the physical, emotional, spiritual, psychological, and social wellness of the community in relation to the health issue being suffered (Minelli, & Breckon, 2009). Chronic diseases are currently the leading causes of death in the community due to their complexity and the severe effects on human health. The community health promotion and education program will be provided by the ‘Health Concerns Coalition’ which will be made up of the following partners; community religious groups, Cancer Supportive Care Foundation, an association of cancer-survivor patients, nutritional organizations, and the local authority.
1. Cancer Supportive Care Foundation – This is an important part of the coalition as it will offer technical expertise in education and diagnosis of chronic diseases. The foundation team will include medical experts who will diagnose the community members of any chronic illnesses. Examinations for diseases such as breast cancer, prostate cancer, diabetes and blood pressure will be conducted by this partner as they will provide modern machines needed for the diagnosis of chronic illnesses.
2. Community religious groups – Community religious groups ca ...
AcademyHealth Engagement, Empowerment, Enhancement: The Role of Consumers in ...Whitney Bowman-Zatzkin
2:45pm-4:15pm
Engagement, Empowerment, Enhancement: The Role of Consumers in Health Care and Advocacy
Moderator: Whitney Bowman-Zatzkin, Flip the Clinic
Strategies and Tactics for Achieving Meaningful Consumer Engagement
Claire Brindis, Director, Institute for Health Policy Studies
Speakers:
Tom Workman, American Institutes for Research (AIR)
Amanda Otero, Health Care Organizer, TakeAction Minnesota
Barriers and Enablers Associated with Differentiated Models of ART Distributi...JSI
In an effort to expand access to antiretroviral treatment (ART), countries across sub-Saharan Africa have begun to implement and scale up differentiated approaches to ART distribution, particularly at the community level. These distribution models are typically designed to cater to stable adult patients and aim to bring ART closer to where patients live, which, in turn, serves to decongest clinics and reduce the overall strain on a country’s health system. While documentation on the results of these models exists, there is limited information on the specific barriers and enablers that have impacted the implementation of such models. This cross-country study describes various models of differentiated ART distribution and the barriers and enablers associated with their implementation.
The community models of ART distribution that were explored were: community adherence clubs, outreach and community distribution points.
It was concluded that While differentiated models of ART distribution aim to broaden patient access to ART, models that provide these services at the community level have additional challenges and considerations that should be assessed and planned for prior to implementation. Two important barriers seen across all countries assessed included stigma and poor linkage to care. Peer support and education for both patients and providers were noted as important drivers of the success of community models. Intensive education at the front-end of scale-up can help providers effectively market the community-level models and help patients pick a model that would work best for them. Understanding these barriers and enablers will help country programs effectively and efficiently implement differentiated models of ART distribution to fit varying contexts, and allow for rapid scale-up, resulting in expanded access to ART and the ability to better meet the demands of patients on ART on a global level.
This poster was presented at the Fifth Global Symposium on Health Systems Research in Liverpool in October by Nikki Davis.
Building Capacity to Improve Population Health using a Social Determinants of...Practical Playbook
The Practical Playbook
National Meeting 2016
www.practicalplaybook.org
Bringing Public Health and Primary Care Together: The Practical Playbook National Meeting was at the Hyatt Regency in Bethesda, MD, May 22 - 24, 2016. The meeting was a milestone event towards advancing robust collaborations that improve population health. Key stakeholders from across sectors – representing professional associations, community organizations, government agencies and academic institutions – and across the country came together at the National Meeting to help catalyze a national movement, accelerate collaborations by fostering skill development, and connect with like-minded individuals and organizations to facilitate the exchange of ideas to drive population health improvement.
The National Meeting was also a significant source of tools and resources to advance collaboration. These tools and resources are available below and include:
Session presentations and materials
Poster session content
Photos from the National Meeting
The conversation started at the National Meeting is continuing in a LinkedIn Group "Working Together for Population Health" and Twitter. Use #PPBMeeting to provide feedback on the National Meeting.
The Practical Playbook was developed by the de Beaumont Foundation, the Duke University School of Medicine Department of Community and Family Medicine, the Centers for Disease Control and Prevention (CDC), and the Health Resources & Services Administration (HRSA).
To accomplish community health goals and its aims the following approaches are to be utilized by community health professionals:-
1)persuasive approach 2)enforcement 3)team approach 4)community involvement 5)Intersectorial approach
For adventurous travel blog please visit http://wilsontom.blogspot.com
Similar to Use of Community Health Data for Shared Accountability (20)
In October 2022, the COVID-19 Vaccine Collaborative Supply Planning Initiative (VCSP) held its second in-person retreat for its network of stakeholders and partners involved in COVID-19 vaccine supply planning from global, regional, and country levels. During the retreat, each country presented its COVID-19 vaccine supply planning context at a poster reception. Wish you’d been there? Check out the posters here
Expert Panelists: Dr. Jason Reed, Biomedical HIV Prevention
Technical Advisor, Jhpiego & Dr. More Mungati, STAR-L Director, EGPAF, Lesotho
Moderator: Dr. Seema Ntjabane, Care & Treament Specialist, USAID-Lesotho
Expert panelists:
Dr. Tafadzwa Chakare, Technical Director, Jhpiego, Lesotho
Dr. More Mungati, STAR-L Director, EGPAF Lesotho
Facilitator:
Dr. Seema Ntjabane, Care & Treatment Specialist, USAID-Lesotho
Panelists:
Dr. Abiye Kalaiwo is a Public Health Specialist and USAID's Nigeria's technical lead for Key Populations, managing PEPFAR's
single largest Key Populations program. He has over 12 years of experience in HIV and infectious disease programs at the national level.
Dr. Jason Reed offers more than 12 years of experience in public health surveillance and medical epidemiology, specifically in HIV surveillance systems, prevention programming, and implementation research at state, national and international levels.
At the end of the training, participants will be able to:
State the indications for PrEP
State the eligibility for PrEP
Name the 5 main eligibility criteria for PrEP
Explain how to exclude Acute HIV Infection
Expert Panelists:
Dr. Abiye Kalaiwo, Program Manager, USAID/Nigeria
Dr. Jason Reed, Biomedical HIV Prevention Technical Advisor, Jhpiego
Moderator:
Olawale Durosinmi-Etti, JSI Nigeria
Speakers discuss PrEP counseling, special situations, and other topics covered in training modules three and four. During this webinar, expert speakers review key highlights from modules three and four, and respond to questions from participants.
Part one: https://www.slideshare.net/jsi/prep-elearning-discussion-i
Speakers discuss PrEP eligibility, management, and other topics covered in training modules one and two. During this webinar, expert speakers will review key highlights from the first two modules, share Nigeria specific guidance, and respond to questions from participants.
Part 2: https://www.slideshare.net/jsi/prep-elearning-discussion-2
Presentation by Jeff Sanderson at "Post-Ebola Survivors - Research and Recovery Lessons from West Africa," a USAID Brown Bag on May 2, 2019 at USAID/Crystal City.
Together with NIH/PREVAIL, today’s session focuses on learnings from these programs in relation to survivor care and post-outbreak recovery of health services and health systems.
Facilitator: Jeff Sanderson, Team Leader, West Africa Post-Ebola Programs, JSI R&T/APC
The Presenters:
Dr. Libby Higgs, Global Health Science Advisor for the Division of Clinical Research at NIAID, NIH (confirmed)
Dr. Meba Kagone, former Chief of Party for ETP&SS, Guinea, JSI/APC (confirmed)
Dr. Rose Macauley, former Chief of Party for ETP&SS, Liberia, JSI/APC (confirmed)
Jeff Sanderson (for Dr. Kwame Oneill, former Director of the Program Implementation Unit, Ministry of Health and Sanitation, Sierra Leone)
Background:
The Ebola Transmission Prevention & Survivor Services (ETP&SS) program included four components; country programs in Guinea, Liberia and Sierra Leone, and a regional program designed to share best practices and lessons learned.
ETP&SS assisted these governments to prevent further Ebola transmission, reduce stigma and other barriers to care for survivors when accessing health services, support the strengthening of needed specialty services, and build more resilient and self-sustaining health systems.
The regional program sought to ensure the sharing of lessons learned and best practices across the three countries and the region through meetings, exchanges and conferences with partners such as NIH, WHO, and the West African Consortium.
Funded by the Global Health Bureau through the Advancing Partners & Communities Project, John Snow Research & Training Institute implemented the program from July 2016 through July/August 2018.
Implementing ETP and SS: The Liberia ExperienceJSI
Presentation by Dr. Rose Macauley at "Post-Ebola Survivors - Research and Recovery Lessons from West Africa," a USAID Brown Bag on May 2, 2019 at USAID/Crystal City.
Together with NIH/PREVAIL, today’s session focuses on learnings from these programs in relation to survivor care and post-outbreak recovery of health services and health systems.
Facilitator: Jeff Sanderson, Team Leader, West Africa Post-Ebola Programs, JSI R&T/APC
The Presenters:
Dr. Libby Higgs, Global Health Science Advisor for the Division of Clinical Research at NIAID, NIH (confirmed)
Dr. Meba Kagone, former Chief of Party for ETP&SS, Guinea, JSI/APC (confirmed)
Dr. Rose Macauley, former Chief of Party for ETP&SS, Liberia, JSI/APC (confirmed)
Jeff Sanderson (for Dr. Kwame Oneill, former Director of the Program Implementation Unit, Ministry of Health and Sanitation, Sierra Leone)
Background:
The Ebola Transmission Prevention & Survivor Services (ETP&SS) program included four components; country programs in Guinea, Liberia and Sierra Leone, and a regional program designed to share best practices and lessons learned.
ETP&SS assisted these governments to prevent further Ebola transmission, reduce stigma and other barriers to care for survivors when accessing health services, support the strengthening of needed specialty services, and build more resilient and self-sustaining health systems.
The regional program sought to ensure the sharing of lessons learned and best practices across the three countries and the region through meetings, exchanges and conferences with partners such as NIH, WHO, and the West African Consortium.
Funded by the Global Health Bureau through the Advancing Partners & Communities Project, John Snow Research & Training Institute implemented the program from July 2016 through July/August 2018.
Ebola Transmission Prevention and Survivor Services Program, GuineaJSI
Presentation by Dr. Meba Kagone at "Post-Ebola Survivors - Research and Recovery Lessons from West Africa," a USAID Brown Bag on May 2, 2019 at USAID/Crystal City.
Together with NIH/PREVAIL, today’s session focuses on learnings from these programs in relation to survivor care and post-outbreak recovery of health services and health systems.
Facilitator: Jeff Sanderson, Team Leader, West Africa Post-Ebola Programs, JSI R&T/APC
The Presenters:
Dr. Libby Higgs, Global Health Science Advisor for the Division of Clinical Research at NIAID, NIH (confirmed)
Dr. Meba Kagone, former Chief of Party for ETP&SS, Guinea, JSI/APC (confirmed)
Dr. Rose Macauley, former Chief of Party for ETP&SS, Liberia, JSI/APC (confirmed)
Jeff Sanderson (for Dr. Kwame Oneill, former Director of the Program Implementation Unit, Ministry of Health and Sanitation, Sierra Leone)
Background:
The Ebola Transmission Prevention & Survivor Services (ETP&SS) program included four components; country programs in Guinea, Liberia and Sierra Leone, and a regional program designed to share best practices and lessons learned.
ETP&SS assisted these governments to prevent further Ebola transmission, reduce stigma and other barriers to care for survivors when accessing health services, support the strengthening of needed specialty services, and build more resilient and self-sustaining health systems.
The regional program sought to ensure the sharing of lessons learned and best practices across the three countries and the region through meetings, exchanges and conferences with partners such as NIH, WHO, and the West African Consortium.
Funded by the Global Health Bureau through the Advancing Partners & Communities Project, John Snow Research & Training Institute implemented the program from July 2016 through July/August 2018.
These slides were presented by Dr. Henry Nagai during JSI’s Index Testing & Partner Notification for HIV Epidemic Control webinar on April 11th, 2019. Dr. Nagai is currently the Project Director/Chief of Party for the JSI-implemented USAID Strengthening the Care Continuum project in Ghana with a focus on HIV and key populations. Using funding from USAID and PEPFAR, the Project is improving the capacity of the Government of Ghana and civil society partners to provide quality and comprehensive HIV services for key populations and people living with HIV.
HIV Index Testing: The USAID DISCOVER-Health Project Experience in Zambia JSI
This was presented by Kalasa Mwansa during the Index Testing & Partner Notification for HIV Epidemic Control webinar on April 11th, 2019. The USAID DISCOVER- Health Project Experience aims to increase the use of high quality, integrated health services in specific target groups, and to provide integrated health products and services in a sustainable manner. In addition, it aims to contribute to HIV epidemic control and provides HIV index testing at every ART site.
Root Cause Analysis: A Community Engagement Process for Identifying Social De...JSI
This presentation serves as a training of trainers for the root cause analysis process, where participants will be able to train their organizational staff and community members on the process. In addition, it shows how it can be used for community engagement, coalition building, and to identify the root causes of HIV.
Setting Them up for Failure: Why Parents Struggle to Adhere to Infant Safe Sl...JSI
This poster was presented by Christin D'Ovidio at the National Conference on Health Communication, Marketing & Media.
Each year in Vermont, 4-6 infants die of unsafe sleep environments. The Vermont Department of Health contracted with JSI Research and Training Institute, Inc. (JSI), to study the major barriers Vermont parents and professionals face with regard to infant safe sleep. The research examined: what parents know, have heard, or find confusing about infant safe sleep practices; decisions around infant safe sleep practice; and response to existing infant safe sleep materials.
Some of the major themes with implications for future
communication efforts included parents’ need to be respected as good and competent caregivers, the desire for information that addresses the unique sleep challenges in their family, and
a skepticism of infant safe sleep research and messaging.
Although parents are highly motivated to do what is best for their baby and are aware of the basic infant safe sleep guidelines, parents who struggle the follow the guidelines feel they must choose between sleep and safety, or adapt the guidelines as their version of “safe sleep.”These parents feel they are being set up for failure, due to a lack of guidance to get their baby to sleep in a safe sleep environment. Parents want assistance grounded in the reality of the challenges
and choices they face to get their babies to sleep while keeping
them safe.
Binge-Free 603: What's Your Reason? Preventing Binge Drinking in Young Adults...JSI
This poster was presented by Christin D'Ovidio at the National Conference on Health Communication, Marketing & Media.
Through a contract with the NH Department of Health and Human Services, JSI conducted peer-crowd/peer-group validation and formative research to inform a public health prevention campaign targeting young adults (YA), aged 21-25, identified as most likely to engage in the misuse of alcohol.
The campaign (Binge-Free 603: What’s Your Reason?) addresses binge drinking behaviors and utilizes harm reduction messaging to create an effective marketing mix. JSI used a social norming, a social marketing approach, as the strategic planning framework for developing a campaign to decrease the prevalence of binge drinking in NH YA.
The resulting, highly-targeted campaign includes video production, illustration, social media assets (Facebook, Instagram, Youtube, Snapchat), A/B testing and geo-targeting to further hone effective messaging and reach, and a website.
USAID Community Capacity for Health Program (Mahefa Miaraka)JSI
How Can Population, Health, and Environment Projects Learn from Family Planning High Impact Practices?
JSI’s Yvette Ribaira shares best practices from Madagascar in a new webinar.
On February 6th, JSI population, health, and environment (PHE) expert Dr. Yvette Ribaira shared insights from her experience in Madagascar during a webinar examining the link between PHE programs and high-impact practices (HIPs) drawn from family planning activities.
Watch the webinar here: https://bit.ly/2SKbuvG
Dr. Ribaira, a medical doctor, has spent her career in public health strengthening the Madagascar’s health system, with a specific focus on community health in the last decade. She currently leads the JSI’s USAID Community Capacity for Health Program in Madagascar, locally known as Mahefa Miaraka, which implements the Population Health and Environment (PHE) Activity, funded by Advancing Partners and Communities.
The webinar was hosted by the PACE (https://thepaceproject.org/) (Policy, Advocacy, and Communication Enhanced for Population and Reproductive Health) project and included presenters from the Population Reference Bureau and USAID.
Read more about JSI’s work on population, health, and environment, as well as family planning, in Madagascar and around the world at www.jsi.com
USAID Community Capacity for Health Program (Mahefa Miaraka): Re-engaging Pop...JSI
This presentation was given by Yvette Ribaira at the International Conference on Family Planning (ICFP) in Kigali, Rwanda in November 2018. (This is the English version of the presentation).
In Madagascar, there are 80% endemic species, 80% of the country is rural, 72% of the population is poor, with only 2.7% population growth. There are over exploitation and destruction of natural resources and lack of access to family planning in rural areas.
Program implications:
1. Partnership for integration health, population, environment
2. Coverage in universal health by delegation of tasks to CAs
3. Increased productivity by women and men
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Ethanol (CH3CH2OH), or beverage alcohol, is a two-carbon alcohol
that is rapidly distributed in the body and brain. Ethanol alters many
neurochemical systems and has rewarding and addictive properties. It
is the oldest recreational drug and likely contributes to more morbidity,
mortality, and public health costs than all illicit drugs combined. The
5th edition of the Diagnostic and Statistical Manual of Mental Disorders
(DSM-5) integrates alcohol abuse and alcohol dependence into a single
disorder called alcohol use disorder (AUD), with mild, moderate,
and severe subclassifications (American Psychiatric Association, 2013).
In the DSM-5, all types of substance abuse and dependence have been
combined into a single substance use disorder (SUD) on a continuum
from mild to severe. A diagnosis of AUD requires that at least two of
the 11 DSM-5 behaviors be present within a 12-month period (mild
AUD: 2–3 criteria; moderate AUD: 4–5 criteria; severe AUD: 6–11 criteria).
The four main behavioral effects of AUD are impaired control over
drinking, negative social consequences, risky use, and altered physiological
effects (tolerance, withdrawal). This chapter presents an overview
of the prevalence and harmful consequences of AUD in the U.S.,
the systemic nature of the disease, neurocircuitry and stages of AUD,
comorbidities, fetal alcohol spectrum disorders, genetic risk factors, and
pharmacotherapies for AUD.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Acute scrotum is a general term referring to an emergency condition affecting the contents or the wall of the scrotum.
There are a number of conditions that present acutely, predominantly with pain and/or swelling
A careful and detailed history and examination, and in some cases, investigations allow differentiation between these diagnoses. A prompt diagnosis is essential as the patient may require urgent surgical intervention
Testicular torsion refers to twisting of the spermatic cord, causing ischaemia of the testicle.
Testicular torsion results from inadequate fixation of the testis to the tunica vaginalis producing ischemia from reduced arterial inflow and venous outflow obstruction.
The prevalence of testicular torsion in adult patients hospitalized with acute scrotal pain is approximately 25 to 50 percent
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Oleg Kshivets
RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0).
CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Couples presenting to the infertility clinic- Do they really have infertility...
Use of Community Health Data for Shared Accountability
1. Use of Community
Health Data for Shared
Accountability
Tariq Azim, MBBS, DM
MEASURE Evaluation
John Snow, Inc.
Stephanie Mullen, DrPH
MEASURE Evaluation
John Snow, Inc.
February 2018
2. The Community Is Not
in the Spotlight
• Dissemination and use of data generated by the health
system are traditionally limited to the health system.
• The community is not viewed as:
o A decision maker when it comes to the health system
o A consumer or user of health data
• As a result:
o The community is disengaged and does not play an active
role in improving its own health status.
o The health system is not held accountable to the community
it serves.
o Promotion of community involvement is externally driven.
o There is a lack of community leadership and ownership of
interventions to improve the community’s own health.
2
3. Community Ownership &
Accountability
• Ownership requires:
oTaking responsibility
oWith that comes accountability
• Accountability:
oCommitting to decisions and/or actions and
holding oneself answerable for those actions
and their consequences
3
4. Shared Accountability to
Ensure Health
• Shared accountability is defined as a process by
which partners hold one another responsible for
the commitments that they have voluntarily made
to each other (Institute of Medicine, 2011).
• Both the community & the health system (public
and/or private) are accountable for:
o Sharing health and related information
o Taking actions to improve/maintain health
o Publicly reporting and answering questions about those
decisions and/or actions
4
5. Shared Accountability for Health
at the Community Level
5
Purpose:
• Create an enabling socio/political
environment of mutual trust and transparency
between the community and the health
system
• Support the taking of collective responsibility
and commitment to shared accountability to
improve health service delivery
• Contribute to the overall health of the
community
6. Basic Principles: Community Health
Data Use for Shared Accountability
• The community takes the leadership role in running the
forum/meeting
• Use an existing forum at the community level
• The community and the health system both share health
and related data/information
o Health status, service coverage, disease occurrences, service
availability, maternal & infant deaths
• Mutually decide on the health priorities and voluntarily
commit to taking responsibility for addressing health priorities
• Promote transparency and open sharing of data while
ensuring privacy and security
6
7. Qualitative Monitoring of Forum
Performance
7
Legend:
Green = desired performance
Yellow = acceptable performance
Red = unfavorable situation
Health System
Shared Information Took Actions
Community
Shared
Information
Box 1: Both the
health system and
the community
shared information
Box 2: Community
provided
information; health
system acted on it
(health system’s
responsiveness)
Took Actions Box 3: Health system
shared information;
community acted
on it (community
engagement in
taking action)
Box 4: No information
was shared, but both
the health system
and community
acted on their own
9. Shared Accountability: Cases
• Disease epidemics: sharing responsibilities and working in
tandem
o Liberia Ebola crisis
There was widespread noncompliance with government-
imposed cremation to prevent viral spread.
Traditional and religious leaders influenced the
development of World Health Organization guidelines on
safe burials with dignity, which became government policy
at the end of 2014.
10. Shared Accountability: Cases
• Community-based maternal death surveillance
o Accra, Ghana
A modified survey system of community-based
reproductive age mortality using six questions was
implemented in the Bosomtwa district of Accra
o Malawi
Community-linked maternal death review: Communities
and health facility staff worked in partnership to investigate
and respond to maternal deaths occurring in communities
and at health facilities
11. Shared Accountability: Cases
• Community-based tuberculosis directly observed treatment,
short course (TB-DOTS): accountability on both sides
o Mozambique
Clients choose their DOTS with support from the local
volunteers, known as padrinhos
Example of community taking responsibility for
supervising TB-DOTS
Padrinhos make themselves accountable to the larger
community regarding adherence to DOTS by the
clients of TB services.
12. This presentation was produced with the support of the United States
Agency for International Development (USAID) under the terms of MEASURE
Evaluation cooperative agreement AID-OAA-L-14-00004. MEASURE
Evaluation is implemented by the Carolina Population Center, University of
North Carolina at Chapel Hill in partnership with ICF International; John
Snow, Inc.; Management Sciences for Health; Palladium; and Tulane
University. Views expressed are not necessarily those of USAID or the United
States government.
www.measureevaluation.org